Inogen’s Executive VP of Operations to Retire

Inogen Inc., a medical technology company offering respiratory products for use in the homecare setting, has announced that after nearly 15 years of support to Inogen’s growth and success, Matt Scribner, Inogen’s executive vice president of Operations, plans to leave the company effective Jan. 2nd, 2019.
 
The company has appointed Bart Sanford as Inogen’s executive vice president of Operations; Scribner is facilitating a transition to ensure an orderly and effective shift of responsibilities. Most recently, Sanford was senior vice president of Operations at Cepheid Inc., a molecular diagnostics company and subsidiary of Danaher Corporation.
 
“Matt has been a part of the company’s success and I want to thank him for his many contributions to Inogen over the years and wish him the best in his future endeavors,” said CEO Scott Wilkinson. “We are looking forward to Bart’s contributions as we continue to drive portable oxygen concentrators to become the standard of care for ambulatory oxygen patients worldwide in this large and growing market.”
 
Inogen is innovation in oxygen therapy. The company company that develops, manufactures, and markets oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.